Equity research analysts covering VieMed Healthcare, Inc. (NASDAQ/TSX: VMD) maintain positive consensus forecasts, with average 12-month institutional price targets hovering around $11.00 per share. These projections are driven by continuous organic growth in active ventilator patient counts, expanding remote patient monitoring programs, and scalable operating margins across its nationwide healthcare network.